Literature DB >> 27465911

Soy Reduces Bone Turnover Markers in Women During Early Menopause: A Randomized Controlled Trial.

Thozhukat Sathyapalan1, Mo Aye1, Alan S Rigby2, William D Fraser3, Natalie J Thatcher4, Eric S Kilpatrick5, Stephen L Atkin6.   

Abstract

Menopausal estrogen loss leads to an increased bone loss. Soy isoflavones can act as selective estrogen receptor modulators, their role in bone turnover is unclear. The primary outcome was assessing changes in plasma bone turnover markers. The secondary outcomes were assessing changes in cardiovascular risk markers including insulin resistance, blood pressure, and lipid profile. We performed a double-blind randomized parallel study in which 200 women within 2 years after the onset of their menopause were randomized to 15 g soy protein with 66 mg isoflavone (SPI) or 15 g soy protein alone (SP), daily for 6 months. There was a significant reduction in type I collagen crosslinked beta C-telopeptide (βCTX) (bone-resorption marker) with SPI supplementation (0.40 ± 0.17 versus 0.15 ± 0.09 μg/L; p < 0.01) compared to SP supplementation (0.35 ± 0.12 versus 0.35 ± 0.13 μg/L; p = 0.92) after 6 months. There was also a significant reduction in type I procollagen-N-propeptide (P1NP) (bone formation marker) with SPI supplementation (50.5 ± 25.0 versus 34.3 ± 17.6 μg/L; p < 0.01), more marked between 3 and 6 months. Following SPI there was a significant reduction in fasting glucose, fasting insulin, insulin resistance, and systolic blood pressure whereas no significant changes in these parameters was observed with SP. There were no significant changes in fasting lipid profile and diastolic blood pressure with either preparation. There was a significant increase in TSH and reduction in free thyroxine (p < 0.01) with SPI supplementation though free tri-iodothyronine was unchanged. In conclusion, soy protein with isoflavones may confer a beneficial effect on bone health, analogous to the mode of action of antiresorptive agents, albeit to a less magnitude. There was a significant improvement of cardiovascular risk markers, but a significant increase in TSH and reduction in free thyroxine after SPI supplementation indicating a detrimental effect on thyroid function.
© 2016 American Society for Bone and Mineral Research. © 2016 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE TURNOVER MARKERS; CADIOVASCULAR RISK MARKERS; P1NP; PHYTOESTROGENS; SOY ISOFLAVONES; THYROID FUNCTION; βCTX

Mesh:

Substances:

Year:  2016        PMID: 27465911     DOI: 10.1002/jbmr.2927

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  12 in total

Review 1.  Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

Authors:  S Hüser; S Guth; H G Joost; S T Soukup; J Köhrle; L Kreienbrock; P Diel; D W Lachenmeier; G Eisenbrand; G Vollmer; U Nöthlings; D Marko; A Mally; T Grune; L Lehmann; P Steinberg; S E Kulling
Journal:  Arch Toxicol       Date:  2018-08-21       Impact factor: 5.153

2.  The Effect of High Dose Isoflavone Supplementation on Serum Reverse T3 in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women.

Authors:  Thozhukat Sathyapalan; Josef Köhrle; Eddy Rijntjes; Alan S Rigby; Soha R Dargham; Eric S Kilpatrick; Stephen L Atkin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-22       Impact factor: 5.555

3.  Systematic Review and Meta-analysis on the Effect of Soy on Thyroid Function.

Authors:  Jemiliat Otun; Amirhossein Sahebkar; Linda Östlundh; Stephen L Atkin; Thozhukat Sathyapalan
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

4.  Thyroid Mediation of the Isoflavone Effects on Osteoporotic Bone: The Endocrine Interference With a Beneficial Outcome.

Authors:  Branka Šošić-Jurjević; Vladimir Ajdžanović; Branko Filipović; Walter Severs; Verica Milošević
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-11       Impact factor: 5.555

Review 5.  Botanicals in Postmenopausal Osteoporosis.

Authors:  Wojciech Słupski; Paulina Jawień; Beata Nowak
Journal:  Nutrients       Date:  2021-05-11       Impact factor: 5.717

Review 6.  Effects of Soy Isoflavones on Biochemical Markers of Bone Metabolism in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Wiesław Kanadys; Agnieszka Barańska; Agata Błaszczuk; Małgorzata Polz-Dacewicz; Bartłomiej Drop; Maria Malm; Krzysztof Kanecki
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

7.  Soy Protein Improves Cardiovascular Risk in Subclinical Hypothyroidism: A Randomized Double-Blinded Crossover Study.

Authors:  Thozhukat Sathyapalan; Zeeshan Javed; Alan S Rigby; Eric S Kilpatrick; Stephen L Atkin
Journal:  J Endocr Soc       Date:  2017-04-03

8.  Effect of soy on bone turn-over markers in men with type 2 diabetes and hypogonadism - a randomised controlled study.

Authors:  T Sathyapalan; M Aye; A S Rigby; W D Fraser; E S Kilpatrick; S L Atkin
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

9.  The Effect of Phytoestrogen on Thyroid in Subclinical Hypothyroidism: Randomized, Double Blind, Crossover Study.

Authors:  Thozhukat Sathyapalan; Alison J Dawson; Alan S Rigby; Natalie J Thatcher; Eric S Kilpatrick; Stephen L Atkin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-09-11       Impact factor: 5.555

Review 10.  Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances.

Authors:  Hardeep Singh Tuli; Muobarak Jaber Tuorkey; Falak Thakral; Katrin Sak; Manoj Kumar; Anil Kumar Sharma; Uttam Sharma; Aklank Jain; Vaishali Aggarwal; Anupam Bishayee
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.